Avelumab Plus Axitinib Shows Promise in Advanced GIST ...Middle East

Medscape - News
Avelumab Plus Axitinib Shows Promise in Advanced GIST
A phase 2 AXAGIST trial finds that avelumab combined with axitinib achieves durable disease control in patients with advanced gastrointestinal stromal tumours. Medscape News UK

Read More Details
Finally We wish PressBee provided you with enough information of ( Avelumab Plus Axitinib Shows Promise in Advanced GIST )

Apple Storegoogle play

Also on site :

Most viewed in News